Literature DB >> 22199394

Axenfeld-Rieger syndrome: new perspectives.

Ta C Chang1, C Gail Summers, Lisa A Schimmenti, Alana L Grajewski.   

Abstract

Axenfeld-Rieger syndrome is a genetic disease affecting multiple organ systems. In the eye, this condition manifests with varying degrees of anterior segment dysgenesis and carries a high risk of glaucoma. Other associated systemic issues include cardiovascular outflow tract malformations, craniofacial abnormalities and pituitary abnormalities, which can result in severe endocrinological sequelae. Recent advances in molecular genetics have identified two major genes, PITX2 and FOXC1, demonstrating a wide spectrum of mutations, which aids in the molecular diagnosis of the disease, although evidence exists to implicate other loci in this condition. The management of individuals affected by Axenfeld-Rieger syndrome requires a multidisciplinary approach and would include dedicated surveillance and management of glaucoma, sensorineural hearing loss, and cardiac, endocrinological, craniofacial and orthopaedic abnormalities.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22199394     DOI: 10.1136/bjophthalmol-2011-300801

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  33 in total

1.  A Novel Mutation in PITX2 in a Patient with Axenfeld-Rieger Syndrome.

Authors:  Susan J Hassed; Shibo Li; Weihong Xu; Ashley C Taylor
Journal:  Mol Syndromol       Date:  2017-01-20

2.  Axenfeld-Rieger syndrome-associated mutants of the transcription factor FOXC1 abnormally regulate NKX2-5 in model zebrafish embryos.

Authors:  Qinxin Zhang; Dong Liang; Yunyun Yue; Luqingqing He; Nan Li; Dongya Jiang; Ping Hu; Qingshun Zhao
Journal:  J Biol Chem       Date:  2020-07-06       Impact factor: 5.157

3.  Mutations of conserved non-coding elements of PITX2 in patients with ocular dysgenesis and developmental glaucoma.

Authors:  Meredith E Protas; Eric Weh; Tim Footz; Jay Kasberger; Scott C Baraban; Alex V Levin; L Jay Katz; Robert Ritch; Michael A Walter; Elena V Semina; Douglas B Gould
Journal:  Hum Mol Genet       Date:  2017-09-15       Impact factor: 6.150

4.  Identification of a novel frameshift mutation in PITX2 gene in a Chinese family with Axenfeld-Rieger syndrome.

Authors:  Hou-fa Yin; Xiao-yun Fang; Chong-fei Jin; Jin-fu Yin; Jin-yu Li; Su-juan Zhao; Qi Miao; Feng-wei Song
Journal:  J Zhejiang Univ Sci B       Date:  2014-01       Impact factor: 3.066

Review 5.  FoxC1-dependent regulation of vascular endothelial growth factor signaling in corneal avascularity.

Authors:  Hyun-Young Koo; Tsutomu Kume
Journal:  Trends Cardiovasc Med       Date:  2012-08-29       Impact factor: 6.677

6.  The clinical outcomes of keratoplasty in irreversible corneal decompensation secondary to Axenfeld-Rieger syndrome.

Authors:  Ting Yu; Jing Hong; Ge-Ge Xiao; Rong-Mei Peng
Journal:  Int Ophthalmol       Date:  2022-05-20       Impact factor: 2.029

7.  Mutations in zebrafish pitx2 model congenital malformations in Axenfeld-Rieger syndrome but do not disrupt left-right placement of visceral organs.

Authors:  Yongchang Ji; Sharleen M Buel; Jeffrey D Amack
Journal:  Dev Biol       Date:  2016-06-11       Impact factor: 3.582

Review 8.  Malformation syndromes associated with disorders of sex development.

Authors:  John M Hutson; Sonia R Grover; Michele O'Connell; Samuel D Pennell
Journal:  Nat Rev Endocrinol       Date:  2014-06-10       Impact factor: 43.330

9.  Development and clinical validation of a real-time PCR assay for PITX2 DNA methylation to predict prostate-specific antigen recurrence in prostate cancer patients following radical prostatectomy.

Authors:  Dimo Dietrich; Oliver Hasinger; Lionel L Bañez; Leon Sun; Geert J van Leenders; Thomas M Wheeler; Chris H Bangma; Nicolas Wernert; Sven Perner; Stephen J Freedland; John M Corman; Michael M Ittmann; Amy L Lark; John F Madden; Arndt Hartmann; Philipp Schatz; Glen Kristiansen
Journal:  J Mol Diagn       Date:  2012-12-22       Impact factor: 5.568

10.  Surgical management in primary congenital glaucoma: four debates.

Authors:  Ta C Chang; Kara M Cavuoto
Journal:  J Ophthalmol       Date:  2013-05-22       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.